Femasys is trading 13.8% up at $3.26 in pre-market, rebounding from last week’s sharp slide and choppy trading.

  • No fresh company-specific news, earnings, FDA updates, or analyst calls have appeared so far this morning.
  • The move currently looks like an isolated pre-market swing rather than a reaction to a clear headline or sector trend.